InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-10 · accession 0001127602-22-017328 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-13 2022-06-10 GILD Pletcher Brett A EVP, Corp Affairs, Gen Counsel F - Tax $60.74 -280 33.4K -0.8% -$17.0K
D 2022-06-13 2022-06-10 GILD Pletcher Brett A EVP, Corp Affairs, Gen Counsel M - OptEx — +782 33.7K +2% —
D 2022-06-13 2022-06-10 GILD Pletcher Brett A EVP, Corp Affairs, Gen Counsel M - OptEx — -782 16.5K -5% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-10 F D 280 $60.74 33,426 D — —
2 Common Common Stock 2022-06-10 M A 782 — 33,706 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Derivative Restricted Stock Unit 2022-06-10 M D 782 — 16,519 D — · — to — 782 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.